Molecular cytogenetic delineation of 17q translocation breakpoints in neuroblastoma cell lines

Genes Chromosomes and Cancer

Volumn 23, Issue 2, 1998, Pages 116-122

  Łastowska, Maria ^a,b   Van Roy, Nadine ^c   Bown, Nick ^a   Speleman, Frank ^c   Lunec, John ^a   Strachan, Tom ^a   Pearson, Andrew D J ^a   Jackson, Michael S ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b Institute of Paediatrics   (Poland)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 17Q; CHROMOSOME BREAKAGE; CHROMOSOME MAP; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 17; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; HUMAN; HUMAN CELL; NEUROBLASTOMA; PRIORITY JOURNAL; SURVIVAL;

EID: 0031687133     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-2264(199810)23:2<116::aid-gcc4>3.0.co;2-5     Document Type: Article

References (38)

1. Albertsen HM, Smith SA, Mazoyer S, Kujimoto E, Stevens J, Williams B, Rodriguez P, Cropp CS, Shjepcevic P, Carlson M, Robertson M, Bradley P, Lawrence E, Harrington T, Sheng ZM, Hoopes R, Sternberg N, Brothman A, Callahan R, Pouder B, White R (1994) A physical map and candidate genes in the BRCA1 region on chromosome 7q12-21. Nat Genet 7:472-179.
2. Ambrosini G, Adida C, Altieri DC (1997) A novel antiapoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917-921.
3. Avet-Loiseau H, Venuat AM, Bernard J, Laibovitch MP, Hartmann O, Bernheim A (1995) Morphologic and molecular cytogenetics in neuroblastoma. Cancer 75:1694-1699.
4. Biedler JL, Helson L, Spengler BA (1973) Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33:2643-2652.
5. Biedler JL, Spengler BA (1976) A novel chromosome abnormality in human neuroblastoma and antifolate-resistant Chinese hamster cell lines in culture. J Natl Cancer Inst 57:683-695.
6. Brinkschmidt C, Christiansen H, Terpe HJ, Simon R, Boecker W, Lampert K, Stoerkel S (1997) Comparative genomic hybridization (CGH) analysis of neuroblastomas: An important methodological approach in paediatric tumor pathology. J Pathol 181:394-400.
7. Brodeur GM, Sekhon GS, Goldstein NM (1977) Chromosomal aberration in human neuroblastomas. Cancer 40:2256-2263.
8. Brodeur GM, Fong C (1989) Molecular biology and genetics of human neuroblastoma. Cancer Genet Cytogenet 41:153-174.
9. Caron H, van Sluis P, van Roy N, de Kraker J, Speleman F, Voute PA, Westerveld A, Slater R, Versteeg R (1994) Recurrent 1:17 translocations in human neuroblastoma reveal nonhomologous mitotic recombination during the S/G2 phase as a novel mechanism for loss of heterozygosity. Am J Hum Genet 55:341-347.
10. Caron H (1995) Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavorable prognostic markers in neuroblastoma. Med Ped Oncol 24:215-221.
11. Chang CL, Zhu X, Thoraval DH, Ungar D, Rawwas J, Hora N, Strahler JR, Hanash SM (1994) nm23-H1 mutation in neuroblastoma. Nature 370:335-336.
12. Chang CL, Strahler JR, Thoraval DH, Qian MG, Hinderer R, Hanash SM (1996) A nucleoside diphosphate kinase A(nm23-H1) serine 120→glycine substitution in advanced stage neuroblastoma affects enzyme stability and alters protein-protein interaction. Oncogene 12:659-667.
13. Christiansen H, Lampert F (1988) Tumor karyotype discriminates between good and bad prognostic outcome in neuroblastoma. Br J Cancer 57:121-126.
14. Christiansen H, Christiansen NM, Wagner F, Altannberger M, Lampert F (1990) Neuroblastoma: Inverse relationship between expression of N-myc and NGF-r. Oncogene 5:437-440.
15. Cowell JK, Rupniak HT (1983) Chromosomal analysis of human neuroblastoma cell line TR14 showing double minutes and an aberration involving chromosome 1. Cancer Genet Cytogenet 9:273-280.
16. Cox D, Yuncken C, Spriggs AI (1965) Minute chromatin bodies in malignant tumors of childhood. Lancet 2:55-58.
17. Donti E, Longo L, Tonini GP, Verdona G, Melodia A, Lanino E, Cornaglia-Ferraris P (1988) Cytogenetic and molecular study of two human neuroblastoma cell lines. Cancer Genet Cytogenet 930:225-231.
18. Gilbert F, Feder M, Balaban G, Brangman D, Lurie DK, Podolsky R, Rinaldt V, Vinikoor N, Weisband Y (1984) Human neuroblastomas and abnormalities of chromosomes 1 and 17. Cancer Res 44:5444-5449.
19. Hailat N, Keim DR, Melhem RF, Zhu X, Eckerskorn C, Brodeur GM, Reynolds CP, Seeger RC, Lottspeich F, Strahler JR, Hanash SM (1991) High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J Clin Invest 88:341-345.
20. Keats B (1992) Genetic mapping: Chromosomes 6-22. Am J Hum Genet 34:730-742.
21. Kogner P, Barbany G, Dominici C, Castello MA, Raschella G, Persson H (1993) Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Cancer Res 53:2044-2050.
22. Łastowska M, Roberts P, Pearson ADJ, Lewis I, Wolstenholme J, Bown N (1997a) Promiscuous translocations of chromosome arm 17q in human neuroblastomas. Genes Chromosomes Cancer 19:143-149.
23. Łastowska M, Nacheva E, McGuckin A, Curtis A, Grace C, Pearson A, Bown N (1997b) Comparative genomic hybridization study of primary neuroblastoma tumors. Genes Chromosomes Cancer 18: 162-169.
24. Łastowska M, Cotterill S, Pearson ADJ, Roberts P, McGuckin A, Lewis I, Bown N (1997c) Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients. Eur J Cancer 33:1627-1633.
25. Leone A, Seeger RC, Hong CM, Hu YY, Arboleda MJ, Brodeur GM, Stram D, Slamon DY, Steeg PS (1993) Evidence for nm23 RNA overexpression. DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene 8:855-865.
26. Meddeb M, Danglot G, Chudoba I, Venuat AM, Avet-Loiseau H, Vasseur B, Le Paslier D, Terrier-Lacombe MJ, Hartmann O, Bernheim A (1996) Additional copies of a 25 Mb chromosomal region originating from 17q23.1-17qter are present in 90% of high-grade neuroblastomas. Genes Chromosomes Cancer 17:156-165.
27. NIH/CEPH Collaborative Mapping Group (1992) A comprehensive genetic linkage map of the human genome. Science 258:67-79.
28. Plantaz, D, Mohapatra G, Matthay KK, Pellarin M, Seeger R, Feuerstein BG (1997) Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. Am J Pathol 150:81-89.
29. Reynolds CP, Biedler JL, Spengler BA, Reynolds DA, Ross RA, Frenkel EP, Smith RG (1986) Characterization of human neuroblastoma cell lines established before and after therapy. J Natl Cancer Inst 76:375-387.
30. Savelyeva L, Corvi R, Schwab M (1994) Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells. Am J Hum Genet 55:334-340.
31. Schwab M, Alitalo K, Klempnauer KH, Varmus HE, Bishop JM, Gilbert F, Brodeur S, Goldstein M, Trent JM (1983) Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumor. Nature 305:245-248.
32. Seeger RC, Brodeur GM, Schwab M, Varmus HE, Bishop JM (1985) Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224:1121-1124.
33. Speleman F, Van Roy N, Wiegant J, Dierick AM, Uyttendaele D, Leroy JG (1992) Molecular cytogenetic analysis of a complex t(10;11;22) translocation in Ewing's sarcoma. Genes Chromosomes Cancer 4:188-191.
34. Tumilowicz JJ, Nichols WW, Cholon JJ, Greene AE (1970) Definition of a continuous human cell line derived from neuroblastoma. Cancer Res 30:2110-2118.
35. Van Roy N, Laureys G, Cheng NC, Willem P, Opdenakker G, Versteeg R, Speleman F (1994) 1;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines. Genes Chromosomes Cancer 10:103-114.
36. Van Roy N, Cheng NC, Laureys G, Opdenakker G, Versteeg R, Speleman F (1995) Molecular cytogenetic analysis of 1;17 translocations in neuroblastoma. Eur J Cancer 4:530-535.
37. Van Roy N, Jauch A, Van Gele M, Laureys G, Versteeg R, De Paepe A, Cremer T, Speleman F (1997) Comparative genomic hybridization analysis of human neuroblastomas: Detection of distal 1p deletions and further molecular genetic characterization of neuroblastoma cell lines. Cancer Genet Cytogenet 97:135-142.
38. Varesco L, Caligo MA, Simi P, Black DM, Nardini V, Casarino L, Rocchi M, Ferrara G, Solomon E, Bevilacqua G (1992) The nm23 gene maps to human chromosome band 17q22 and shows a restriction fragment length polymorphism with Bg/II. Genes Chromosomes Cancer 4:84-88.